Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
AVEO Pharmaceuticals Inc
AVEO Pharmaceuticals Inc
Activities:
Manufacturing
Research & Development
X
LinkedIn
Trending Articles
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
US court lifts modified consent decree on Xellia’s Cleveland facility
The Modified Consent Decree imposed on Xellia's Cleveland facility in 2016 has been vacated, receiving a VAI
Lonza's AI-enabled small molecule development tool launches
The company's AI-enabled Route Scouting Service will optimise synthetic route identification when identifying novel APIs
Autoscribe Informatics’ new Australia office supports business growth
The company's move to West Lakes Adelaide expands its ability to service the Asia Pacific region in digitalising laboratory information
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Research & Development
Aveo Oncology to cut 140 jobs as part of restructuring
Astellas pulls out of financing future trials of tivozanib in renal cell carcinoma
Regulatory
Anticancer agent – tivozanib
Blocking vascular endothelial growth factor can have an impact on angiogenesis, and numerous drugs have already been developed that target VEGF receptors
AVEO Pharmaceuticals and Boehringer Ingelheim in manufacturing agreement
Deal covers large-scale process development and clinical manufacturing of ficlatuzumab
Subscribe now